Agenus inc. class action reminder: robbins llp reminds agen investors of the november 5, 2024 lead plaintiff deadline in the class action against agenus inc.

San diego, ca / accesswire / october 18, 2024 / robbins llp reminds investors that a shareholder filed a class action on behalf of all persons and entities who purchased or otherwise acquired agenus inc. (nasdaq:agen) securities between january 23, 2023 and july 17, 2024. agenus is a clinical-stage biotechnology company that discovers and develops immuno-oncology ("i-o") products in the u.s. and internationally.
AGEN Ratings Summary
AGEN Quant Ranking